Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation
出版年份 2011 全文链接
标题
Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation
作者
关键词
-
出版物
FASEB JOURNAL
Volume 25, Issue 8, Pages 2711-2721
出版商
FASEB
发表日期
2011-05-07
DOI
10.1096/fj.10-176602
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effects of a Cannabinoid Receptor 2 Selective Antagonist on the Inflammatory Reaction to Titanium Particles In Vivo and In Vitro
- (2013) F Zhou et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- β-Caryophyllene Inhibits Dextran Sulfate Sodium-Induced Colitis in Mice through CB2 Receptor Activation and PPARγ Pathway
- (2011) Allisson Freire Bento et al. AMERICAN JOURNAL OF PATHOLOGY
- Inflammatory Bowel Disease
- (2010) Arthur Kaser et al. Annual Review of Immunology
- Gastrointestinal and liver adverse effects of drugs used for treating IBD
- (2010) Gerhard Rogler BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Emerging Biologics in the Treatment of Inflammatory Bowel Disease: What is Around the Corner?
- (2010) Gionata Fiorino et al. CURRENT DRUG TARGETS
- Endocannabinoid biosynthesis and inactivation, from simple to complex
- (2010) Giulio G. Muccioli DRUG DISCOVERY TODAY
- Mechanisms and Efficacy of Immunobiologic Therapies for Inflammatory Bowel Diseases
- (2010) Nilanjan Ghosh et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Inhibition of titanium particle-induced inflammatory osteolysis through inactivation of cannabinoid receptor 2 by AM630
- (2010) D. C. Geng et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
- The endocannabinoid system links gut microbiota to adipogenesis
- (2010) Giulio G Muccioli et al. Molecular Systems Biology
- The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors
- (2010) William R Marrs et al. NATURE NEUROSCIENCE
- Future biologic targets for IBD: potentials and pitfalls
- (2010) Gil Y. Melmed et al. Nature Reviews Gastroenterology & Hepatology
- The Cannabinoid 1 Receptor (CNR1) 1359 G/A Polymorphism Modulates Susceptibility to Ulcerative Colitis and the Phenotype in Crohn's Disease
- (2010) Martin Storr et al. PLoS One
- Chemokines as Novel Therapeutic Targets for Inflammatory Bowel Disease
- (2009) Miyuki Nishimura et al. Annals of the New York Academy of Sciences
- Characterization of Monoacylglycerol Lipase Inhibition Reveals Differences in Central and Peripheral Endocannabinoid Metabolism
- (2009) Jonathan Z. Long et al. CHEMISTRY & BIOLOGY
- Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease
- (2009) S. Brand GUT
- Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability
- (2009) P. D. Cani et al. GUT
- Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis
- (2009) Martin A. Storr et al. INFLAMMATORY BOWEL DISEASES
- Ulcerative Colitis Induces Changes on the Expression of the Endocannabinoid System in the Human Colonic Tissue
- (2009) Lucia Marquéz et al. PLoS One
- Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo
- (2009) J. Z. Long et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Distribution and function of monoacylglycerol lipase in the gastrointestinal tract
- (2008) Marnie Duncan et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- The cannabinoid receptor-1 antagonist rimonabant inhibits platelet activation and reduces pro-inflammatory chemokines and leukocytes in Zucker rats
- (2008) A Schäfer et al. BRITISH JOURNAL OF PHARMACOLOGY
- Activated Endocannabinoid System in Coronary Artery Disease and Antiinflammatory Effects of Cannabinoid 1 Receptor Blockade on Macrophages
- (2008) Koichi Sugamura et al. CIRCULATION
- Distinct Cytokine Patterns Identified from Multiplex Profiles of Murine DSS and TNBS-Induced Colitis
- (2008) Philip Alex et al. INFLAMMATORY BOWEL DISEASES
- Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors
- (2008) Martin A. Storr et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects
- (2008) Jonathan Z Long et al. Nature Chemical Biology
- Microglial activation and TNF production mediate altered CNS excitability following peripheral inflammation
- (2008) K. Riazi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An optimized GC–MS method detects nanomolar amounts of anandamide in mouse brain
- (2007) Giulio G. Muccioli et al. ANALYTICAL BIOCHEMISTRY
- Effect of the cannabinoid CB1 receptor antagonist rimonabant on nociceptive responses and adjuvant-induced arthritis in obese and lean rats
- (2007) T Croci et al. BRITISH JOURNAL OF PHARMACOLOGY
- From inflammation to sickness and depression: when the immune system subjugates the brain
- (2007) Robert Dantzer et al. NATURE REVIEWS NEUROSCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now